IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of Clostridioides difficile infection

References

• Beinortas T, Burr NE, Wilcox MH, Subramanian V. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis. Lancet Infect Dis. 2018;18(9):1035–10. doi:10.1016/S1473-3099(18)30285-8.
   Google Scholar
• Rodríguez C, Romero E, Garrido-Sanchez L, Alcaín-Martínez G, Andrade RJ, Taminiau B, Daube G, García-Fuentes E. Microbiota insights in clostridium difficile infection and inflammatory bowel disease. Gut Microbes. 2020;12(1):1725220. doi:10.1080/19490976.2020.1725220.
   Google Scholar
• Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol. 2006;4(7):529–536. doi:10.1038/nrmicro1441.
   Google Scholar
• Zhang M, Liang W, Gong W, Yoshimura T, Chen K, Wang JM. The critical role of the antimicrobial peptide LL-37/ CRAMP in protection of colon microbiota balance, mucosal homeostasis, anti-inflammatory responses, and resistance to carcinogenesis. Crit Rev Immunol. 2019;39(2):83–92. doi:10.1615/CritRevImmunol.2019030225.
   Google Scholar
• Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo, Jr. CA Jr, Koeffler HP, Thadhani R. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis. 2009;48(4):418–424. doi:10.1086/596314.
   Google Scholar
• Sarker P, Mily A, Mamun AA, Jalal S, Bergman P, Raqib R, Gudmundsson GH, Agerberth B. Ciprofloxacin affects host cells by suppressing expression of the endogenous antimicrobial peptides cathelicidins and beta-defensin-3 in colon epithelia. Antibiotics (Basel). 2014;3(3):353–374. doi:10.3390/antibiotics3030353.
   Google Scholar
• Liu R, Suárez JM, Weisblum B, Gellman SH, McBride SM. Synthetic polymers active against clostridium difficile vegetative cell growth and spore outgrowth. J Am Chem Soc. 2014;136(41):14498. doi:10.1021/ja506798e.
   Google Scholar
• Hing TC, Ho S, Shih DQ, Ichikawa R, Cheng M, Chen J, Chen X, Law I, Najarian R, Kelly CP, et al. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice. Gut. 2013;62(9):1295–1305. doi:10.1136/gutjnl-2012-302180.
   Google Scholar
• Nuding S, Frasch T, Schaller M, Stange EF, Zabel LT. Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficile. Antimicrob Agents Chemother. 2014;58(10):5719–5725. doi:10.1128/AAC.02542-14.
   Google Scholar
• Martens EC, Neumann M, Desai MS. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol. 2018;16(8):457–470. doi:10.1038/s41579-018-0036-x.
   Google Scholar
• Heuberger C, Pott J, Maloy KJ. Why do intestinal epithelial cells express MHC class II? Immunology. 2021;162(4):357–367. doi:10.1111/imm.13270.
   Google Scholar
• Kim SH, Yang IY, Kim J, Lee KY, Jang YS. Antimicrobial peptide LL-37 promotes antigen-specific immune responses in mice by enhancing Th17-skewed mucosal and systemic immunities. Eur J Immunol. 2015;45(5):1402–1413. doi:10.1002/eji.201444988.
   Google Scholar
• Duplantier AJ, van Hoek ML. The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds. Front Immunol. 2013;4:143. doi:10.3389/fimmu.2013.00143.
   Google Scholar
• Lin JX, Leonard WJ. Fine-Tuning Cytokine Signals. Annu Rev Immunol. 2019;37(1):295–324. doi:10.1146/annurev-immunol-042718-041447.
   Google Scholar
• Cao J, Wang D, Xu F, Gong Y, Wang H, Song Z, Li D, Zhang H, Li D, Zhang L, et al. Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia. EMBO Mol Med. 2014;6(1):120–140. doi:10.1002/emmm.201302890.
   Google Scholar
• Wang L, Cao J, Li C, Zhang L. IL-27/IL-27 receptor signaling provides protection in Clostridium difficile-induced colitis. J Infect Dis. 2018;217(2):198–207. doi:10.1093/infdis/jix581.
   Google Scholar
• Dong S, Zhang X, He Y, Xu F, Li D, Xu W, Wang H, Yin Y, Cao J. Synergy of IL-27 and TNF-α in regulating CXCL10 expression in lung fibroblasts. Am J Respir Cell Mol Biol. 2013;48(4):518–530. doi:10.1165/rcmb.2012-0340OC.
   Google Scholar
• Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. Society for Healthcare Epidemiology of America, Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–455.
   Google Scholar
• Cadwell K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat Rev Immunol. 2016;16(11):661–675. doi:10.1038/nri.2016.100.
   Google Scholar
• Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol. 2005;174(8):4901–4907. doi:10.4049/jimmunol.174.8.4901.
   Google Scholar
• Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun. 2002;70(2):953–963. doi:10.1128/IAI.70.2.953-963.2002.
   Google Scholar
• Van Der Does AM, Bergman P, Agerberth B, Lindbom L. Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections. J Leukoc Biol. 2012;92(4):735–742. doi:10.1189/jlb.0412178.
   Google Scholar
• Tu H, Lai X, Li J, Huang L, Liu Y, Cao J. Interleukin-26 is overexpressed in human sepsis and contributes to inflammation, organ injury, and mortality in murine sepsis. Crit Care. 2019;23(1):290. doi:10.1186/s13054-019-2574-7.
   Google Scholar